|
Mar 13
|
11 Oversold NASDAQ Stocks To Buy Right Now
|
|
Mar 13
|
PacBio's (PACB) New Panel to Aid Its Clinical Research Solution
|
|
Mar 12
|
PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions
|
|
Mar 7
|
Director David Meline Acquires 40,000 Shares of Pacific Biosciences of California Inc (PACB)
|
|
Jan 16
|
PacBio's (PACB) New PanDNA Kit Ready to Boost DNA Extraction
|
|
Jan 15
|
PacBio Announces New Nanobind PanDNA Kit Enabling HiFi Optimized DNA Extraction Solutions
|
|
Jan 9
|
PacBio (PACB) Preliminary Q4 Revenues Boosted by Revio Sales
|
|
Jan 8
|
PacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively
|
|
Dec 27
|
PacBio to Present at 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 27
|
CVRx (CVRX) Moves 24.2% Higher: Will This Strength Last?
|
|
Dec 20
|
12 Most Promising Gene Editing Stocks According to Hedge Funds
|
|
Dec 10
|
12 Best Genomics Stocks To Buy Now
|
|
Dec 6
|
Shockwave Medical (SWAV) Down 1% Since Last Earnings Report: Can It Rebound?
|
|
Dec 1
|
Why Is IQVIA (IQV) Up 12.4% Since Last Earnings Report?
|
|
Sep 12
|
PacBio Announces PacBio Capital
|
|
Sep 8
|
Cathie Wood's Buying These 3 Stocks Hand Over Fist
|
|
Sep 7
|
PacBio Announces Collaboration with Leading Library Preparation Automation Partners
|
|
Apr 26
|
12 Gene Editing Stocks With the Best Long-Term Potential
|